Search research articles
Contact Us
Filters
Showing results (31-40 of 51) with videos related to
Page
of 6
Sort By:
Experimental Hematology & Oncology
|
January 3, 2025
Prominent efficacy and good safety of sequential CD19 and CD22 CAR-T therapy in relapsed/refractory adult B-cell acute lymphoblastic leukemia
Tingting Yang, Yetian Dong, Mingming Zhang, et al.
HLA
|
May 15, 2026
CD19/BCMA-Targeted Chimeric Antigen Receptor-T Cell Therapy for Anti-HLA Antibody Sensitisation in Patients With Acute Leukaemia: A Pilot Clinical Study
Haiqiong Zheng, Houli Zhao, Xinyi Zhu, et al.
Leukemia
|
July 3, 2026
CD7 chimeric antigen receptor T cells in patients with relapsed or refractory CD7-positive acute myeloid leukemia
Mingming Zhang, Lianxuan Liu, Shan Fu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
January 15, 2022
Inhibition of Calcium Signaling Prevents Exhaustion and Enhances Anti-Leukemia Efficacy of CAR-T Cells via SOCE-Calcineurin-NFAT and Glycolysis Pathways
Mi Shao, Xinyi Teng, Xin Guo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 22, 2021
Risk Factors Associated with Durable Progression-Free Survival in Patients with Relapsed or Refractory Multiple Myeloma Treated with Anti-BCMA CAR T-cell Therapy
Mingming Zhang, Linghui Zhou, Houli Zhao, et al.
Bone Marrow Transplantation
|
August 20, 2025
Safety and efficacy of autologous humanized CD19 CAR-T cell therapy for relapsed/refractory B-cell non-Hodgkin lymphoma
Yetian Dong, Tingting Yang, Mengyu Zhao, et al.
Nature Aging
|
July 17, 2024
A metabolic atlas of blood cells in young and aged mice identifies uridine as a metabolite to rejuvenate aged hematopoietic stem cells
Xiangjun Zeng, Ce Shi, Yingli Han, et al.
Cell Reports. Medicine
|
February 2, 2024
Inhibition of CD38 enzymatic activity enhances CAR-T cell immune-therapeutic efficacy by repressing glycolytic metabolism
Yue Huang, Mi Shao, Xinyi Teng, et al.
The Lancet. Haematology
|
February 1, 2023
GPRC5D CAR T cells (OriCAR-017) in patients with relapsed or refractory multiple myeloma (POLARIS): a first-in-human, single-centre, single-arm, phase 1 trial
Mingming Zhang, Guoqing Wei, Linghui Zhou, et al.
Journal of Hematology & Oncology
|
July 22, 2021
Dasatinib enhances anti-leukemia efficacy of chimeric antigen receptor T cells by inhibiting cell differentiation and exhaustion
Hao Zhang, Yongxian Hu, Mi Shao, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 51) with videos related to
Sort By:
Page
of 6
Experimental Hematology & Oncology
|
January 3, 2025
Prominent efficacy and good safety of sequential CD19 and CD22 CAR-T therapy in relapsed/refractory adult B-cell acute lymphoblastic leukemia
Tingting Yang, Yetian Dong, Mingming Zhang, et al.
HLA
|
May 15, 2026
CD19/BCMA-Targeted Chimeric Antigen Receptor-T Cell Therapy for Anti-HLA Antibody Sensitisation in Patients With Acute Leukaemia: A Pilot Clinical Study
Haiqiong Zheng, Houli Zhao, Xinyi Zhu, et al.
Leukemia
|
July 3, 2026
CD7 chimeric antigen receptor T cells in patients with relapsed or refractory CD7-positive acute myeloid leukemia
Mingming Zhang, Lianxuan Liu, Shan Fu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
January 15, 2022
Inhibition of Calcium Signaling Prevents Exhaustion and Enhances Anti-Leukemia Efficacy of CAR-T Cells via SOCE-Calcineurin-NFAT and Glycolysis Pathways
Mi Shao, Xinyi Teng, Xin Guo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 22, 2021
Risk Factors Associated with Durable Progression-Free Survival in Patients with Relapsed or Refractory Multiple Myeloma Treated with Anti-BCMA CAR T-cell Therapy
Mingming Zhang, Linghui Zhou, Houli Zhao, et al.
Bone Marrow Transplantation
|
August 20, 2025
Safety and efficacy of autologous humanized CD19 CAR-T cell therapy for relapsed/refractory B-cell non-Hodgkin lymphoma
Yetian Dong, Tingting Yang, Mengyu Zhao, et al.
Nature Aging
|
July 17, 2024
A metabolic atlas of blood cells in young and aged mice identifies uridine as a metabolite to rejuvenate aged hematopoietic stem cells
Xiangjun Zeng, Ce Shi, Yingli Han, et al.
Cell Reports. Medicine
|
February 2, 2024
Inhibition of CD38 enzymatic activity enhances CAR-T cell immune-therapeutic efficacy by repressing glycolytic metabolism
Yue Huang, Mi Shao, Xinyi Teng, et al.
The Lancet. Haematology
|
February 1, 2023
GPRC5D CAR T cells (OriCAR-017) in patients with relapsed or refractory multiple myeloma (POLARIS): a first-in-human, single-centre, single-arm, phase 1 trial
Mingming Zhang, Guoqing Wei, Linghui Zhou, et al.
Journal of Hematology & Oncology
|
July 22, 2021
Dasatinib enhances anti-leukemia efficacy of chimeric antigen receptor T cells by inhibiting cell differentiation and exhaustion
Hao Zhang, Yongxian Hu, Mi Shao, et al.
Page
of 6